(Q49049243)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: a retrospective observational study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

Mathieu Coeman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Yannick van Durme

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ellen Deschepper

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Ingel Demedts

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Peter Smeets

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Guy Joos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Guy Brusselle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

2 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic advances in respiratory disease

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

377-386

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

Asthma severity and medical resource utilisation

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Airway remodeling measured by multidetector CT is increased in severe asthma and correlates with pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Global strategy for asthma management and prevention: GINA executive summary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Long-term macrolide therapy in chronic inflammatory airway diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Anti-inflammatory effects of macrolide antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Matrix metalloproteinases in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Costs of asthma are correlated with severity: a 1-yr prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Clarithromycin suppresses airway hyperresponsiveness and inflammation in mouse models of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Long-term efficacy and safety of clarithromycin treatment in patients with diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Erythromycin and diffuse panbronchiolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Macrolides as immunomodulatory medications for the therapy of chronic lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

The impact of bronchiectasis in clinical presentation of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Diffuse panbronchiolitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Macrolides for chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Innate immune activation in neutrophilic asthma and bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Differential proteolytic enzyme activity in eosinophilic and neutrophilic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Bronchial dilatation in asthma: relation to clinical and sputum indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Immunomodulatory effects of macrolides in the lung: lessons from in-vitro and in-vivo models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Asthma: defining of the persistent adult phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Effects of claritromycin on inflammatory parameters and clinical conditions in children with bronchiectasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

Cystic fibrosis: scoring system with thin-section CT

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465811406771

21 January 2018

Identifiers

DOI

10.1177/1753465811406771

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21890536%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference